The Clinicopathological Significance of MicroRNA-155 in Breast Cancer: A Meta-Analysis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Zeng, Hui ^a   Fang, Cheng ^a   Nam, Seungyoon ^b   Cai, Qing ^c   Long, Xinghua ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b National Cancer Center   (South Korea)

^c HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; MICRORNA 155; PROGESTERONE RECEPTOR; PROTEIN P53; MICRORNA; MIRN155 MICRORNA, HUMAN;

ARTICLE; BREAST CANCER; CNKI DATABASE; COMPUTER PROGRAM; EMBASE; FEMALE; GENE EXPRESSION; HUMAN; LYMPH NODE METASTASIS; MEDLINE; BREAST TUMOR; CASE CONTROL STUDY; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; META ANALYSIS; METABOLISM; PATHOLOGY; PUBLISHING;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PUBLICATION BIAS;

EID: 84935892778     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/724209     Document Type: Article

References (39)

1. W. C. Hahn and R. A. Weinberg, "Rules for making human tumor cells, "The New England Journal of Medicine, vol. 347, no. 20, pp. 1593-1603, 2002.
2. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function, " Cell, vol. 116, no. 2, pp. 281-297, 2004.
3. G. Meister and T. Tuschl, "Mechanisms of gene silencing by double-strand ed RNA, " Nature, vol. 431, no. 7006, pp. 343-349, 2004.
4. P. D. Zamore and B. Haley, "Ribo-gnome: the big world of small RNAs, " Science, vol. 309, no. 5740, pp. 1519-1524, 2005.
5. G. D. Leva, G. A. Calin, and C. M. Croce, "MicroRNAs: fundamental facts and involvement in human diseases, " Birth Defects Research Part C-Embryo Today: Reviews, vol. 78, no. 2, pp. 180-189, 2006.
6. X. Zhang, L. Zhen, X. Han, J. Shi, X. Qiu, and W. Song, "Expression of three microRNAs in plasma of breast cancer patients, " Chinese Journal of Clinical Oncology, vol. 39, no. 3, pp. 136-140, 2012.
7. W. Kong, H. Yang, L. He, et al., "MicroRNA-155 is regulated by the transforming growth factor β/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA, " Molecular & Cellular Biology, vol. 28, no. 22, pp. 6773-6784, 2008.
8. S. Nam, X. Long, C. Kwon, S. Kim, and K. P. Nephew, "An integrative analysis of cellular contexts, miRNAs and mRNAs reveals network clusters associated with antiestrogen-resistant breast cancer cells, " BMC Genomics, vol. 13, no. 1, article 732, 2012.
9. J. Ferlay, F. Bray, P. Pisani, and D. M. Parkin, GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide IARC Cancer Base No 5, Version 2. 0, IARC Press, Lyon, France, 2004.
10. W. Cao, X. Wang, and J. Li, "Hereditary breast cancer in theHan Chinese population, " Journal of Epidemiology, vol. 23, no. 2, pp. 75-84, 2013.
11. D. Atkins, D. Best, P. A. Briss, et al., "Grading quality of evidence and strength of recommendations, " BritishMedical Journal, vol. 328, p. 1490, 2004.
12. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, "Measuring inconsistency in meta-analyses, " British Medical Journal, vol. 327, no. 7414, pp. 557-560, 2003.
13. R. DerSimonian and R. Kacker, "Random-effects model for meta-analysis of clinical trials: an update, " Contemporary Clinical Trials, vol. 28, no. 2, pp. 105-114, 2007.
14. J. P. T. Higgins and S. G. Thompson, "Quantifying heterogeneity in ameta-analysis, " Statistics inMedicine, vol. 21, no. 11, pp. 1539-1558, 2002.
15. J. Chen, B. Wang, and J. Tang, "Clinical significance of MicoRNA-155 expression in human breast cancer, " Journal of Surgical Oncology, vol. 106, no. 3, pp. 260-266, 2012.
16. S. M. Fu and H. W. Zhang, "The expression of miR-155 and miR-21 in breast cancer tissue, " Chinese Journal of Experimental Surgery, vol. 28, article 1240, 2011.
17. M. M. Hafez, Z. K. Hassan, A. R. N. Zekri, et al., "MicroRNAs and metastasis-related gene expression in egyptian breast cancer patients, " Asian Pacific Journal of Cancer Prevention, vol. 13, no. 2, pp. 591-598, 2012.
18. X. D. Han, X. Y. Zhang, L. L. Zhen, et al., "Circulating miR-155 in serumof patientswithbreast cancer, " Chinese Journal of Surgical Oncology, vol. 5, no. 1, pp. 47-49, 2013.
19. H. M. Heneghan, N. Miller, R. Kelly, J. Newell, and M. J. Kerin, "Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease, " Oncologist, vol. 15, no. 7, pp. 673-682, 2010.
20. G. L. Huang, X. Y. Xue, R. C. Zeng, et al., "Expression of microRNAs in plasma of patients with breast cancer and its clinical significance, " Journal of Wenzhou Medical College, vol. 43, no. 5, pp. 286-290, 2013.
21. M. V. Iorio, M. Ferracin, C. Liu, et al., "MicroRNA gene expression deregulation in human breast cancer, " Cancer Research, vol. 65, no. 16, pp. 7065-7070, 2005.
22. Z. Lu, Y. Ye, D. Jiao, J. Qiao, S. Cui, and Z. Liu, "MiR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status, " Oncology Letters, vol. 4, no. 5, pp. 1027-1032, 2012.
23. M. Ouyang, Y. Li, and S. Ye, "MicroRNA prof iling implies new markers of chemoresistance of triple-negative breast cancer, " Plos ONE, vol. 9, no. 5, Article ID e96228, 2014.
24. F. Mar-Aguilar, J. A. Mendoza-Ramrez, I. Malagon-Santiago, et al., "Serum circulating microRNA prof iling for identification of potential breast cancer biomarkers, " Disease Markers, vol. 34, no. 3, pp. 163-169, 2013.
25. Y. B. Shao, S. Zhang, Y. Liu, et al., "Analysis of serum microRNAs differentially expressed in Breast cancer tissues, " Chinese General Practice, vol. 16, no. 5, pp. 1736-1739, 2013.
26. Y. Sun, M. Wang, G. Lin, et al., "Serum microRNA-155 as a potential biomarker to track disease in breast cancer, " PLoS ONE, vol. 7, no. 10, Article IDe47003, 2012.
27. F. Wang, Z. Zheng, J. Guo, and X. Ding, "Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor, " Gynecologic Oncology, vol. 119, no. 3, pp. 586-593, 2010.
28. X. Q. Wang and J. Zhang, "Abnormal expression of miR-155 in serum of breast cancer patients, " Tian Jin Medical College, 2011.
29. S. Zheng, G. Guo, W. Zhang, et al., "Clinical significance of miR expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis, " Oncology Reports, vol. 27, no. 4, pp. 1149-1155, 2012.
30. E. A. C. Wiemer, "The role of microRNAs in cancer: no small matter, " European Journal of Cancer, vol. 43, no. 10, pp. 1529-1544, 2007.
31. L. Silveri, G. Tilly, J. Vilotte, and F. Le Provost, "MicroRNA involvement in mammary gland development and breast cancer, " Reproduction Nutrition Development, vol. 46, no. 5, pp. 549-556, 2006.
32. M. L. Si, S. Zhu, H. Wu, Z. Lu, F. Wu, and Y.-Y. Mo, "miR-21-mediated tumor growth, " Oncogene, vol. 26, no. 19, pp. 2799-2803, 2007.
33. J. Zhu, X. Hu, G. Guo, et al., "Expression and its clinical significance of miR-155 in human primary breast cancer, " ZhonghuaWai Ke Za Zhi, vol. 48, no. 3, pp. 205-208, 2010.
34. J. Liu, Q. Mao, and Y. Liu, "Analysis of miR-205 and miR-expression in the blood of breast cancer patients, " Chinese Journal of Cancer Research, vol. 25, pp. 46-54, 2013.
35. A. B. Hui, W. Shi, P. C. Boutros, et al., "Robust global micro-RNA prof iling with formalin-fixed paraffin-embedded breast cancer tissues, " Laboratory Investigation, vol. 89, no. 5, pp. 597-606, 2009.
36. G. F. Bian and A. J. Chen, "Correlation study of the expression of miR-21 and miR-155 in the blood and tumor tissue of patients with breast cancer, " Hainan Medical Journal, vol. 23, no. 18, pp. 1-3, 2012.
37. X. D. Huang, X. R. Zhou, H. Li, L. Mao, and F. Liu, "The analysis of expression of miR-155 in Breast cancer tissue and the relationship between the expression and clinical Pathological features, " Chinese Journal of Cancer Prevention and Treatment, vol. 18, no. 22, pp. 1783-1801, 2011.
38. D. C. Allred, J. M. Harvey, M. Berardo, and G. M. Clark, "Prognostic and predictive factors in breast cancer by immunohistochemical analysis, " Modern Pathology, vol. 11, no. 2, pp. 155-168, 1998.
39. T. Norberg, S. Klaar, G. Karf, H. Nordgren, L. Holmberg, and J. Bergh, "Increased p53 mutation frequency during tumor progression-results from a breast cancer cohort, " Cancer Research, vol. 61, no. 22, pp. 8317-8321, 2001.